Rong Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rong Tang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chang Sun
College of Computer Science, Nankai University, Tianjin, China
2 shared publications - Jian Liu
College of Computer Science, Nankai University, Tianjin, China
2 shared publications - Jinmao Wei
College of Computer Science, Nankai University, Tianjin, China
2 shared publications Jipeng Huang
College of Computer Science, Nankai University, Tianjin, China
1 shared publication- Jipeng Huang
Centre for Bioinformatics and Intelligent Medicine, Nankai University , Tianjin 300071
1 shared publication - Minglei Li
College of Computer Science, Nankai University, Tianjin, China
1 shared publication
Latest Publications
- 6 September 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 27 (11) , 5675-5684
Predicting Drug-Protein Interactions by Self-Adaptively Adjusting the Topological Structure of the Heterogeneous Network
Many powerful computational methods based on graph neural networks (GNNs) have been proposed to predict drug-protein interactions (DPIs). It can effectively reduce laboratory workload and the cost of drug discovery and drug repurposing. However, many clinical functions of drugs and proteins are unknown due to their unobserved indications. Therefore, it is difficult to establish a reliable drug-protein heterogeneous network that can describe the relationships between drugs and proteins based on the available information. To solve this problem, we propose a DPI prediction method that can self-adaptively adjust the topological structure of the heterogeneous networks, and name it SATS. SATS establishes a representation learning module based on graph attention network to carry out the drug-protein heterogeneous network. It can self-adaptively learn the relationships among the nodes based on their attributes and adjust the topological structure of the network according to the training loss of the model. Finally, SATS predicts the interaction propensity between drugs and proteins based on their embeddings. The experimental results show that SATS can effectively improve the topological structure of the network. The performance of SATS outperforms several state-of-the-art DPI prediction methods under various evaluation metrics. These prove that SATS is useful to deal with incomplete data and unreliable networks. The case studies on the top section of the prediction results further demonstrate that SATS is powerful for discovering novel DPIs.
- 6 September 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 27 (11) , 5675-5684
Predicting Drug-Protein Interactions by Self-Adaptively Adjusting the Topological Structure of the Heterogeneous Network
Many powerful computational methods based on graph neural networks (GNNs) have been proposed to predict drug-protein interactions (DPIs). It can effectively reduce laboratory workload and the cost of drug discovery and drug repurposing. However, many clinical functions of drugs and proteins are unknown due to their unobserved indications. Therefore, it is difficult to establish a reliable drug-protein heterogeneous network that can describe the relationships between drugs and proteins based on the available information. To solve this problem, we propose a DPI prediction method that can self-adaptively adjust the topological structure of the heterogeneous networks, and name it SATS. SATS establishes a representation learning module based on graph attention network to carry out the drug-protein heterogeneous network. It can self-adaptively learn the relationships among the nodes based on their attributes and adjust the topological structure of the network according to the training loss of the model. Finally, SATS predicts the interaction propensity between drugs and proteins based on their embeddings. The experimental results show that SATS can effectively improve the topological structure of the network. The performance of SATS outperforms several state-of-the-art DPI prediction methods under various evaluation metrics. These prove that SATS is useful to deal with incomplete data and unreliable networks. The case studies on the top section of the prediction results further demonstrate that SATS is powerful for discovering novel DPIs.
- 17 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 20 (3) , 2200-2209
A Deep Neural Network-Based Co-Coding Method to Predict Drug-Protein Interactions by Analyzing the Feature Consistency Between Drugs and Proteins
Exploring drug-protein interactions (DPIs) through computational methods can effectively reduce the workload and the cost of DPI identification. Previous works try to predict DPIs by integrating and analyzing the unique features of drugs and proteins. They cannot adequately analyze the consistency between the drug features and the protein features due to their different semantics. However, the consistency of their features, such as the correlation originating from their sharing diseases, may reveal some potential DPIs. Here we propose a deep neural network-based co-coding method (DNNCC for short) to predict novel DPIs. DNNCC projects the original features of drugs and proteins to a common embedding space through a co-coding strategy. In this way, the embedding features of drugs and proteins have the same semantics. Therefore, the prediction module can discover the unknown DPIs by exploring the feature consistency between drugs and proteins. The experimental results indicate that the performance of DNNCC is significantly superior to five state-of-the-art DPI prediction methods under several evaluation metrics. The superiority of integrating and analyzing the common features of drugs and proteins is proved by the ablation experiments. The novel DPIs predicted by DNNCC verify that DNNCC is a powerful prior tool that can effectively discover potential DPIs.
- 17 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 20 (3) , 2200-2209
A Deep Neural Network-Based Co-Coding Method to Predict Drug-Protein Interactions by Analyzing the Feature Consistency Between Drugs and Proteins
Exploring drug-protein interactions (DPIs) through computational methods can effectively reduce the workload and the cost of DPI identification. Previous works try to predict DPIs by integrating and analyzing the unique features of drugs and proteins. They cannot adequately analyze the consistency between the drug features and the protein features due to their different semantics. However, the consistency of their features, such as the correlation originating from their sharing diseases, may reveal some potential DPIs. Here we propose a deep neural network-based co-coding method (DNNCC for short) to predict novel DPIs. DNNCC projects the original features of drugs and proteins to a common embedding space through a co-coding strategy. In this way, the embedding features of drugs and proteins have the same semantics. Therefore, the prediction module can discover the unknown DPIs by exploring the feature consistency between drugs and proteins. The experimental results indicate that the performance of DNNCC is significantly superior to five state-of-the-art DPI prediction methods under several evaluation metrics. The superiority of integrating and analyzing the common features of drugs and proteins is proved by the ablation experiments. The novel DPIs predicted by DNNCC verify that DNNCC is a powerful prior tool that can effectively discover potential DPIs.